Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Operating Expenses: 2009-2025

Historic Other Operating Expenses for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $103,343.

  • China Pharma Holdings' Other Operating Expenses fell 22.27% to $103,343 in Q3 2025 from the same period last year, while for Sep 2025 it was $467,982, marking a year-over-year decrease of 25.36%. This contributed to the annual value of $534,526 for FY2024, which is 30.09% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Other Operating Expenses is $103,343, which was up 0.02% from $103,324 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Other Operating Expenses registered a high of $440,734 during Q2 2021, and its lowest value of $85,788 during Q1 2025.
  • Its 3-year average for Other Operating Expenses is $144,687, with a median of $132,947 in 2024.
  • In the last 5 years, China Pharma Holdings' Other Operating Expenses crashed by 78.75% in 2021 and then soared by 30.05% in 2022.
  • China Pharma Holdings' Other Operating Expenses (Quarterly) stood at $286,280 in 2021, then increased by 23.75% to $354,261 in 2022, then declined by 24.35% to $267,996 in 2023, then plummeted by 34.50% to $175,527 in 2024, then fell by 22.27% to $103,343 in 2025.
  • Its Other Operating Expenses was $103,343 in Q3 2025, compared to $103,324 in Q2 2025 and $85,788 in Q1 2025.